Advanced Biomed Inc. Common Stock (ADVB) vs DataMEDS AI, Inc. (MEDS)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and DataMEDS AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.75HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
MEDS
DataMEDS AI, Inc.
$3.23HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ADVB vs MEDS
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)MEDS -97.7% (-84.8%/yr)ADVB compounded faster over this window
ADVB MEDS
ADVB vs MEDS: by the numbers
- •ADVB is the larger company ($9M vs $8M market cap).
- •Both run net losses; ADVB's is the smaller (0.00% vs -1100.30% net margin).
Metrics side by side
Valuation
| Metric | ADVB | MEDS |
|---|---|---|
| P/S ratio | N/A | 1.06 |
| P/B ratio | 1.01 | N/A |
Profitability
| Metric | ADVB | MEDS |
|---|---|---|
| Gross margin | 0.00% | -41.30% |
| Operating margin | 0.00% | -347.91% |
| Net margin | 0.00% | -1100.30% |
| ROE | -7.36% | N/A |
| ROIC | -11.06% | -439.90% |
Growth (annualized)
| Metric | ADVB | MEDS |
|---|---|---|
| Total return CAGR (5Y) | N/A | -45.88% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.